Dr. Kirsten Haas

• [ 2025 ]
• [ 2024 ]
• [ 2023 ]
• [ 2022 ]
• [ 2021 ]
• [ 2020 ]
• [ 2019 ]
• [ 2018 ]
• [ 2017 ]
• [ 2016 ]

• 1.

  Veltkamp R, Haas K, Rücker V, Malzahn U, Heeger A, Kinzler D, et al. Association of oral anticoagulants with risk of brain haemorrhage expansion compared to no-anticoagulation. Neurol Res Pract. 2025;7(1):12.
  • [ DOI ]
• 1.

  Harvey KH, Korompoki E, Harvey ER, Fießler C, Malzahn U, Hügen K, et al. Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project. Thromb Haemost. 2025;.
  • [ DOI ]
• 1.

  Hofmann AL, Widmann J, Brandstetter L, Selig U, Haug F, Haug J, et al. Development and application of a clinical core data set for deep brain stimulation in Parkinson’s disease, dystonia or tremor: from data collection to data exchange and data sharing. Neurol Res Pract. 2025;7(1):5.
  • [ DOI ]
• 1.

  Veltkamp R, Korompoki E, Harvey KH, Harvey ER, Fießler C, Malzahn U, et al. Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial. The Lancet [Internet]. 2025;. Available from: https://www.sciencedirect.com/science/article/pii/S0140673625003332
  • [ DOI ]
• 1.

  Brandstetter LS, Schutzmeier M, Grau A, Ahnert J, Klingshirn H, Reuschenbach B, et al. Beschreibung der Charakteristika invasiv beatmeter pflegebedürftiger Patient*innen in Bayern anhand der Nutzung von Routinedaten des MD Bayern. Gesundheitswesen [Internet]. 2025;(EFirst). Available from: http://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2504-0513
  • [ DOI ]
• 1.

  Dieris-Hirche J, Herpertz S, Hebestreit H, Bârlescu L, Berger A, Brandstetter L, et al. Mental disorders in people with undiagnosed diseases presenting to German centres for rare diseases – prevalence, type and relevance. Psychiatry Research [Internet]. 2025;349:116509. Available from: https://www.sciencedirect.com/science/article/pii/S016517812500157X
  • [ DOI ]

• 1.

  Korompoki E, Heuschmann P, Harvey KH, Fiessler C, Malzahn U, Hügen K, et al. Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial. Thromb Haemost. 2024;.
  • [ DOI ]
• 1.

  Schutzmeier M, Brandstetter LS, Stangl S, Ahnert J, Grau A, Gerken L, et al. Development and pilot-testing of an evidence-based quality indicator set for home mechanical ventilation care: the OVER-BEAS project. BMC Health Services Research [Internet]. 2024;24(1):152. Available from: https://doi.org/10.1186/s12913-024-10583-2
  • [ DOI ]
• 1.

  Horn A, Wendel J, Franke I, Bauer A, Baumeister H, Bendig E, et al. The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial. Trials [Internet]. 2024;25(1):767. Available from: https://doi.org/10.1186/s13063-024-08614-8
  • [ DOI ]

• 1.

  Kippnich M, Skazel T, Klingshirn H, Gerken L, Heuschmann P, Haas K, et al. [Analysis of the weaning process in intensive care patients with regard to documentation and transfer to further treatment units]. Med Klin Intensivmed Notfmed. 2023;118(4):269-76.
  • [ DOI ]
• 1.

  Herrmann J, Müller K, Notz Q, Hübsch M, Haas K, Horn A, et al. Prospective single-center study of health-related quality of life after COVID-19 in ICU and non-ICU patients. Sci Rep. 2023;13(1):6785.
  • [ DOI ]
• 1.

  Klingshirn H, Gerken L, Hofmann K, Heuschmann PU, Haas K, Schutzmeier M, et al. [Complexity of outpatient intensive care for ventilated people: Cross-mapping into the standardised NNN-taxonomy]. Pflege. 2023;36(5):259-68.
  • [ DOI ]
• 1.

  Skazel T, Raub M, Haas K, Schutzmeier M, Brandstetter L, Ahnert J, et al. Die notärztliche Versorgung von langzeitbeatmeten Patienten im außerstationären Umfeld – im Spannungsfeld zwischen Intensivmedizin und häuslicher Versorgung. NOTARZT. 2023;.
  • [ DOI ]
• 1.

  Horn A, Stangl S, Parisi S, Bauer N, Roll J, Löffler C, et al. Systematic review with meta-analysis: Stress-management interventions for patients with irritable bowel syndrome. Stress Health. 2023;.
  • [ DOI ]
• 1.

  Hebestreit H, Lapstich AM, Brandstetter L, Krauth C, Deckert J, Haas K, et al. Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort design. EClinicalMedicine. 2023;65:102260.
  • [ DOI ]
• 1.

  Tilch K, Hopff SM, Appel K, Kraus M, Lorenz-Depiereux B, Pilgram L, et al. Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany. BMC Med Ethics. 2023;24(1):84.
  • [ DOI ]

• 1.

  Nielsen PB, Melgaard L, Overvad TF, Jensen M, Larsen TB, Lip GYH. Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study. Stroke. 2022;53(8):2559-68.
  • [ DOI ]
• 1.

  Kippnich M, Skazel T, Klingshirn H, Gerken L, Heuschmann P, Haas K, et al. Analyse des Weaningprozesses bei Intensivpatienten im Hinblick auf Dokumentation und Verlegung in weiterbehandelnde Einheiten [Analysis of the weaning process in intensive care patients with regard to documentation and transfer to further treatment units]. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2022;118.
  • [ DOI ]
• 1.

  Hebestreit H, Zeidler C, Schippers C, de Zwaan M, Deckert J, Heuschmann P, et al. Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort study. Orphanet Journal of Rare Diseases [Internet]. 2022;17(1):47. Available from: https://doi.org/10.1186/s13023-022-02176-1
  • [ DOI ]
• 1.

  Herrmann J, Lotz C, Karagiannidis C, Weber-Carstens S, Kluge S, Putensen C, et al. Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation. Crit Care. 2022;26(1):190.
  • [ DOI ]
• 1.

  Klingshirn H, Gerken L, Hofmann K, Heuschmann PU, Haas K, Schutzmeier M, et al. Comparing the quality of care for long-term ventilated individuals at home versus in shared living communities: a convergent parallel mixed-methods study. BMC Nursing [Internet]. 2022;21(1):224. Available from: https://doi.org/10.1186/s12912-022-00986-z
  • [ DOI ]
• 1.

  Klingshirn H, Gerken L, Hofmann K, Heuschmann PU, Haas K, Schutzmeier M, et al. Komplexität außerstationärer Intensivpflege beatmeter Menschen [Complexity of outpatient intensive care for ventilated people: Cross-mapping into the standardised NNN-taxonomy]. Pflege [Internet]. 2022;:null. Available from: https://econtent.hogrefe.com/doi/abs/10.1024/1012-5302/a000919
  • [ DOI ]
• 1.

  Appel KS, Maier D, Hopff SM, Mitrov L, Stecher M, Scherer M, et al. 1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP). Open Forum Infectious Diseases [Internet]. 2022;9(Supplement_2). Available from: https://doi.org/10.1093/ofid/ofac492.1513
  • [ DOI ]

• 1.

  Klingshirn H, Gerken L, Hofmann K, Heuschmann PU, Haas K, Schutzmeier M, et al. How to improve the quality of care for people on home mechanical ventilation from the perspective of healthcare professionals: a qualitative study. BMC Health Services Research [Internet]. 2021;21(1):774. Available from: https://doi.org/10.1186/s12913-021-06743-3
  • [ DOI ]
• 1.

  Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, et al. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8.
  • [ DOI ]
• 1.

  Skazel T, Kippnich M, Klingshirn H, Gerken L, Heuschmann P, Haas K, et al. [Ventilation Patients between Acute Care and Long-term Out-of-Hospital Ventilation - Routine Documentation based Analysis of the Care Situation]. Pneumologie. 2021;.
  • [ DOI ]

• 1.

  Stangl S, Haas K, Eichner FA, Grau A, Selig U, Ludwig T, et al. Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease—the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry. Pilot and Feasibility Studies [Internet]. 2020;6(1):11. Available from: https://doi.org/10.1186/s40814-019-0541-3
  • [ DOI ]
• 1.

  Stangl S, Haas K, Eggers C, Reese JP, Tönges L, Volkmann J. Versorgung von Parkinson-Patienten in Deutschland. Der Nervenarzt [Internet]. 2020;91(6):493-502. Available from: https://doi.org/10.1007/s00115-020-00890-4
  • [ DOI ]
• 1.

  Haas K, Rücker V, Hermanek P, Misselwitz B, Berger K, Seidel G, et al. Association Between Adherence to Quality Indicators and 7-Day In-Hospital Mortality After Acute Ischemic Stroke. Stroke [Internet]. 2020;51(12):3664-72. Available from: https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.120.029968
  • [ DOI ]

• 1.

  Haas K, Stangl S, Steigerwald F, Matthies C, Gruber D, Kühn AA, et al. Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson’s disease and first year experience of implementation of a nation-wide registry. Parkinsonism & Related Disorders [Internet]. 2019;60:3-9. Available from: https://www.sciencedirect.com/science/article/pii/S1353802019300161
  • [ DOI ]
• 1.

  Wiegering V, Keupp A, Frietsch M, Fiessler C, Haas K, Haubitz I, et al. Role of B cells in chronic graft-versus-host disease after allogeneic stem cell transplantation in children and adolescents. Br J Haematol. 2019;186(5):e133-e137.
  • [ DOI ]
• 1.

  Haas K, Purrucker JC, Rizos T, Heuschmann PU, Veltkamp R. Rationale and design of the Registry of Acute Stroke Under Novel Oral Anticoagulants-prime (RASUNOA-prime). Eur Stroke J. 2019;4(2):181-8.
  • [ DOI ]

• 1.

  Purrucker JC, Wolf M, Haas K, Siedler T, Rizos T, Khan S, et al. Microbleeds in ischemic vs hemorrhagic strokes on novel oral anticoagulants. Acta Neurol Scand. 2018;138(2):163-9.
  • [ DOI ]

• 1.

  Purrucker JC, Haas K, Wolf M, Rizos T, Khan S, Kraft P, et al. Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants. J Stroke. 2017;19(1):67-76.
  • [ DOI ]
• 1.

  Purrucker JC, Rizos T, Haas K, Wolf M, Khan S, Heuschmann PU, et al. Coagulation Testing in Intracerebral Hemorrhage Related to Non-vitamin K Antagonist Oral Anticoagulants. Neurocrit Care. 2017;27(2):208-13.
  • [ DOI ]
• 1.

  Dietz UA, Fleischhacker A, Menzel S, Klinge U, Jurowich C, Haas K, et al. Risk-adjusted procedure tailoring leads to uniformly low complication rates in ventral and incisional hernia repair: a propensity score analysis and internal validation of classification criteria. Hernia. 2017;21(4):569-82.
  • [ DOI ]

• 1.

  Purrucker JC, Haas K, Rizos T, Khan S, Wolf M, Hennerici MG, et al. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants. JAMA Neurol. 2016;73(2):169-77.
  • [ DOI ]
• 1.

  Purrucker JC, Wolf M, Haas K, Rizos T, Khan S, Dziewas R, et al. Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants. Stroke. 2016;47(4):1127-30.
  • [ DOI ]
• 1.

  Purrucker JC, Haas K, Rizos T, Khan S, Poli S, Kraft P, et al. Coagulation Testing in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants. Stroke. 2016;48(1):152-8.
  • [ DOI ]